Oncology
2017-08-19 6.兒童大樓7F會議室 (7F Conf. Rm)
時間主題
13:00 ~ 13:20
瀏覽海報時間
13:20 ~ 13:24
MP021: Prostate health index (PHI) improve prostate cancer detection at initial biopsy in Taiwanese men with PSA 4-10ng/ml
講者: 吳錫金
13:24 ~ 13:28
MP022: The value of prostate health index to predict magnetic resonance imaging lesions during active surveillance: A prospective cohort in Taiwan
講者: 蔣智宏
13:28 ~ 13:32
MP023: Outcome of patients with metastatic castration-resistant prostate cancer after progressive disease of abiraterone acetate
講者: 洪晟鈞
13:32 ~ 13:36
MP024: Prognosis of prostate cancer with initial PSA at diagnosis beyond 1000 ng/ml
講者: 甘弘成
13:36 ~ 13:40
MP025: Urodynamic changes in patients with prostate cancer who have undergone robotic-assisted radical prostatectomy: a comparison with laparoscopic radical prostatectomy
講者: 李宇坤
13:40 ~ 13:44
MP026: The impact of different treatment modality in global quality of life among patients of prostate cancer
講者: 高耀臨
13:44 ~ 13:48
MP027: Efficacy and safety of enzalutamide (ENZ) vs placebo (PL) in chemotherapy- naïve patients (pts) with progressive metastatic castration-resistant prostate cancer (mCRPC): Taiwan subgroup analysis of an Asian multiregional study
講者: 黃書彬
13:48 ~ 13:52
MP028: High-intensity focused ultrasound (HIFU) therapy for localized prostate cancer : Cathy General Hospital experience
講者: 蔡樹衛
13:52 ~ 13:56
MP029: Positive predictive value of multiparametric magnetic resonance imaging in prostate cancer detection: the experience of Tungs’ Taichung Metroharbor Hospital
講者: 盧顥文
13:56 ~ 14:00
MP030: Androgen deprivation therapy duration is associated with abiraterone acetate efficacy in metastatic castration resistance prostate cancer
講者: 李建儀